Gujarat Inject Kerala Limited has scheduled a meeting of its Board of Directors to be held on Wednesday, July 15, 2026. The meeting will take place at the company's Registered Office.
The primary agenda items for the board meeting include:
- Consideration and approval of the Un-Audited Financial Results of the Company for the quarter ended June 30, 2026
- Taking on record the Reports of the Statutory Auditors on the financial results
- Any other business with the permission of the Chair
The disclosure is made pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation is provided for the information of shareholders and members of the company.
The document is signed by Murli Shivshankaran Nair, Managing Director (DIN: 02243039), and includes a digital signature timestamped July 10, 2026 at 22:18:37 +05:30.
Financial Impact
Financial results for the quarter are pending board approval and have not been disclosed in this filing.